miR-1297 sensitizes glioma cells to temozolomide (TMZ) treatment through targeting adrenomedullin (ADM).
J Transl Med
; 20(1): 443, 2022 10 01.
Article
in En
| MEDLINE
| ID: mdl-36183123
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
MicroRNAs
/
Glioma
Limits:
Animals
Language:
En
Journal:
J Transl Med
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
United kingdom